A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:33:34Z
dc.date.available	2017-06-07T07:33:34Z
dc.date.issued	2015
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/7939
dc.language.iso	eng
dc.title	A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
dc.type	Publicación de congreso
dc.authorsophos	Parton, M.
dc.authorsophos	Bardia, A.
dc.authorsophos	Kummel, S.
dc.authorsophos	Estevez, L. G.
dc.authorsophos	Huang, C. S.
dc.authorsophos	Castan, J. C.
dc.authorsophos	Borrego, M. R.
dc.authorsophos	Telli, M. L.
dc.authorsophos	Lluch, A.
dc.authorsophos	Lopez, R.
dc.authorsophos	Beck, J. T.
dc.authorsophos	Ismail-Khan, R.
dc.authorsophos	Chen, S. C.
dc.authorsophos	Hurvitz, S. A.
dc.authorsophos	Mayer, I. A.
dc.authorsophos	Atienza, R. S.
dc.authorsophos	Cameron, S.
dc.authorsophos	Krygowski, M.
dc.authorsophos	Kim, S. B.
dc.identifier.isi	358036900095
dc.identifier.sophos	19305
dc.issue.number	15 SUPPL. 1
dc.journal.title	Journal Of Clinical Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	1014
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	33

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.